Modifications of the 4,4'-residues and SAR studies of Biphalin, a highly potent opioid receptor active peptide (Q34485404)

2 August 2017

title

Modifications of the 4,4'-residues and SAR studies of Biphalin, a highly potent opioid receptor active peptide (English)

1 reference

2 August 2017

0 references

Li G

1

1 reference

2 August 2017

Haq W

2

1 reference

2 August 2017

Xiang L

3

1 reference

2 August 2017

Lou BS

4

1 reference

2 August 2017

Hughes R

5

1 reference

2 August 2017

De Leon IA

6

1 reference

2 August 2017

Davis P

7

1 reference

2 August 2017

Gillespie TJ

8

1 reference

2 August 2017

Romanowski M

9

1 reference

2 August 2017

Zhu X

10

1 reference

2 August 2017

Misicka A

11

1 reference

2 August 2017

Lipkowski AW

12

1 reference

2 August 2017

Porreca F

13

1 reference

2 August 2017

Davis TP

14

1 reference

2 August 2017

Yamamura HI

15

1 reference

2 August 2017

O'Brien DF

16

1 reference

2 August 2017

Hruby VJ

17

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

Bioorganic & Medicinal Chemistry Letters

2 August 2017

published in

1 reference

2 August 2017

volume

8

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

555-560

1 reference

Conformational and topographical considerations in the design of biologically active peptides

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Conformational restrictions of biologically active peptides via amino acid side chain groups

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Constrained peptides: models of bioactive peptides and protein substructures

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Endogenous opioid peptides: multiple agonists and receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Identification of two related pentapeptides from the brain with potent opiate agonist activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Recent developments in the design of receptor specific opioid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Double-enkephalins--synthesis, activity on guinea-pig ileum, and analgesic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Dimeric tetrapeptide enkephalins display extraordinary selectivity for the delta opiate receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Narcotic antagonistic potency of bivalent ligands which contain beta-naltrexamine. Evidence for bridging between proximal recognition sites

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

Synthesis and kappa-opioid antagonist selectivity of a norbinaltorphimine congener. Identification of the address moiety required for kappa-antagonist activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900065-1

7 January 2021

10.1016/S0960-894X(98)00065-1

Identifiers

DOI

1 reference

2 August 2017

1 reference